On August 16, 2022, Jonathan Jorgl, an AIM ImmunoTech Inc. stockholder, together with his nominees, Robert L. Chioini and Michael Rice, reiterated their commitment to proceed with the solicitation of proxies for the election of Robert L. Chioini and Michael Rice to the Company's board of directors at the upcoming 2022 annual meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.376 USD | -1.05% | +7.74% | -14.53% |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
05-15 | AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.53% | 21.48M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.60% | 22.67B | |
-9.81% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- Jonathan Jorgl Reiterates Intent to Proceed with Nominations and Proxy Solicitation